Michael J. Farrell

Chief Executive Officer

Michael J. Farrell (Chief Executive Officer) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in ResMed Inc. (RMD). The largest single filing was $2.3M of RMD (8,009 sh × $282.85, as filed), executed Oct 7 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 12 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$15.7M

shares × price, as filed

Last traded

Sep 8

Filed Sep 10

Median ADV $323.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $39.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 12 filings

Sector per market data · by filing · past 12 months

Most traded names

RMD

ResMed Inc. RMD · 0 buys · 23 sells 23 filings

Recent filings

RMDSALE ResMed Inc. View filing → $1.2M
4,991 sh × $248.46
Exec Jan 7
Filed Jan 8 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $1.3M
4,991 sh × $251.41
Exec Dec 8 2025
Filed Dec 9 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $2.0M
8,011 sh × $249.75
Exec Nov 7 2025
Filed Nov 10 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $2.3M
8,009 sh × $282.85
Exec Oct 7 2025
Filed Oct 9 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $2.2M
8,009 sh × $278.14
Exec Sep 8 2025
Filed Sep 9 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $2.2M
8,009 sh × $279.48
Exec Aug 7 2025
Filed Aug 11 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $2.1M
8,009 sh × $256.72
Exec Jul 7 2025
Filed Jul 9 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $2.0M
8,009 sh × $251.21
Exec Jun 9 2025
Filed Jun 10 2025 · 5:30 PM ET More filings →